The modern approach to intravesical therapy of chronic cystitis
O.D. Nikitin – Bogomolets National Medical University Kyiv
The difficult of treating patients with chronic recurrent cystitis are caused by various factors like virulence of uropathogenic Escherichia coli, and the state of the local resistance of the bladder mucosa and their interaction. Instilan instillations in the treatment of patients with chronic cystitis led to a pronounced positive dynamics of clinical 95% of patients, as well as to reduce the number of recurrences of cystitis more than 2 times, which greatly improved the quality of life of patients. The results allow us to recommend the use of intravesical sodium hyaluronate for the treatment of various forms of chronic cystitis.
Key words: chronic cystitis, intravesical therapy, instilan.
Antes de la aplicación de los productos de este medio informativo, se recomienda consultar a su médico y leer la instrucción.
Información sobre el producto de la destinación médica para la actividad profesional de los especialistas de la Salud. INSTYLAN (INSTYLAN) 0,16% gel viscoso, sin color de ácido hialurónico, no de orígen animal, estéril con PH fisiológico.
INSTYLAN 0,16% está aprobado como producto de la destinación médica de la ІІa clase. Certificado de aceptabilidad de UE. Número de registro: DD 60107286 0001. Productor: Diaco Biofarmaceutici S.R.L. Via Flavia 124, 34147, Trieste, Italy. E-mail: info@diaco.it. www.diaco.it.
